undamentalytics Newsletter
Sign in

Axil Brands, Inc. (AXIL) stock

Add to watchlist

Add holding +

NYSE: AXIL NYSE Personal Care Products Next results ~January 7, 2027

B Fundamentals grade

Axil Brands, Inc. is a US-listed company in the personal care products industry. Its financial year ends in May.

Stock price today

Loading chart…

Third-party market data · may be delayed

Fair value per share

~$2.9

Cash-flow model

Base case. Range ~$2.4–$3.4 across our lower- and higher-growth cases (-0.8%–9.2% a year).

Price vs value

Overvalued

The price is above our entire value range; our base value is 52% below it.

Price used: $5.95, November 2, 2026

Axil Brands, Inc. valuation: adjust assumptions and compare models →

Who’s trading

What company insiders, investment funds and members of Congress have been doing with the stock, from their own filings.

  • Funds7 adding, 5 cuttingOf 1 active managers that changed their stake, 1 added; quarter to June 30, 2026Fund buyers and sellers

Value diary

Our note on each quarter Axil Brands files

Where Axil Brands stands after its latest 10-Q

Revenue for the twelve months to August 2026 was $30m, up 10.3% on a year earlier, slower than the 17.5% growth a quarter earlier. That growth ranks 3 of 17 among the personal care products companies we cover. Free-cash-flow margin rose to 14.5% from 0.0% a year earlier. Operating margin widened to 10.0% from 6.3%. The diluted share count is down 5.5% on a year earlier, which lifts each remaining share. Against its peers on growth, profitability, cash generation and balance sheet, it grades B. It passes 3 of our 3 financial-health checks. Our cash-flow model value is $2.22 a share, against a share price of $5.40.

Source: 10-Q filed October 6, 2026 on SEC EDGAR · Financials · Valuation

Written from the company's filings and our models when each quarter's report arrives. Figures in older notes are as published at the time. Not investment advice.

The Fundamentalytics view

Next results ~January 7, 2027 (estimated)

Axil Brands, Inc.'s trailing-twelve-month revenue grew 10.3% year on year, with a free-cash-flow margin of 14.5%. Where it stands out: long-term debt as % of assets of 0.9% ranks 1 of 13 personal care products companies we cover. Where it lags: change in growth rate of -7.1pp ranks 20 of 21 personal care products companies we cover.

Our discounted-cash-flow model values the business at ~$2.9 per share in the base case (~$2.4–$3.4 across growth scenarios) — model values under stated assumptions, not a price target.

Current signal Free cash flow diverging from earnings: TTM free cash flow grew 41683.6% while net income grew 114.4%: a 41569pp divergence.

Assembled from SEC-filed figures — the full workings are on this page and in our methodology. Observations, not recommendations.

Highlights

How we pick these

Strengths

  • Margins widening. Operating margin is up 3.7 points on a year ago.
  • Shrinking share count. Diluted shares fell 5.5% in a year, so each share owns more of the business.
  • Net cash. Cash exceeds long-term debt by $0.0bn.

Things to watch

  • Priced above our value. The share price of $5.95 is 52% above our value per share of $3.
  • Growth slowing. The growth rate is 7.1 points lower than a quarter earlier.
  • Volatile shares. Over the past year the shares showed annualised volatility of 85% and a beta of 0.1 against the S&P 500.
  • Below peers: stock pay as % of revenue. Stock pay as % of revenue of 4.3% ranks 17 of 18 personal care products companies we cover (median 1.0%).

Latest results: FY2027 Q1

Filed October 6, 2026
Earnings per share
$0.05 against an average estimate of $0.13: missed by 61.5%
Revenue
$6m, down 11.2% on a year earlier
Share reaction
-1.8% in the first session after the results on October 6, 2026, against +0.3% for the S&P 500

Axil Brands' figures from its SEC filings and results release; estimates are the analysts' average. Not a recommendation.

Price chart

  • 1 day+7.8%
  • 1 week+7.4%
  • 1 month-3.6%
  • This year-14.1%
  • 1 year+6.4%
  • S&P 500 this year+11.2%

Closing prices to 2026-11-02. Price change only, dividends excluded.

Loading chart…

Third-party market data · may be delayed

At a glance

Trailing twelve months, from SEC filings

Profitability

Revenue (TTM)
$30.1M
Operating margin
10.0%
Net margin
9.3%
EPS (TTM, diluted)
$0.34

Growth

Revenue growth
+10.3%
Change in growth rate
−7.1 pts
Share count change
−5.5%

Cash

Free cash flow (TTM)
$4.4M
FCF margin
14.5%
Stock pay % of revenue
4.3%

Earnings

Last results
October 6, 2026
Next results (est.)
January 7, 2027

News & updates

Updated October 31, 2026

Company announcements, filed results and changes that matter to shareholders.

  1. Results
  2. Results

Refreshed hourly when new source data is available. Summaries are checked against company releases and SEC filings. Company announcement headlines are labelled when a checked summary is unavailable.

Valuation

Axil Brands, Inc. valuation models and calculator

What the price is pricing in

The share price implies about 24.6% a year of cash-flow growth for five years.That is slower than the 66.7% a year revenue growth Axil Brands has delivered.

Read with care: free cash flow has swung sharply in the past year (often a one-off tax, legal or working-capital item), so the cash-flow base behind this reading may be unusually low or high.

  • Priced in24.6%
  • Last 12 months10.3%
  • 3 years a year-5.7%
  • 5 years a year66.7%

Our cash-flow model with every input fixed except growth over the next five years, solved for the growth at which the model value equals the share price ($5.95, Nov 2, 2026). Cash-flow growth then fades to 2.5% a year; discount rate 8.5%. Delivered figures are revenue growth from SEC filings. This is a model exercise, not investment advice or a forecast of the share price. All companies

Fundamentalytics rating

model v1.6 · 2026-11-03
Sell12-month view
12-month price target
~$2.9
Price used
$5.95close November 2, 2026
Implied change
▼ 52%
Uncertainty
Low

How we got here: a discounted-cash-flow model of Axil Brands, Inc.'s free cash flow after stock-based pay with after-tax interest added back ($568,836, FY2027 Q1 TTM), growing 12% and 6.4% in the next two years (forecasts, guidance and its record), then back to 4.2% by year five, and fading to 2.5%, discounted at 8.5%. Lower and higher growth cases span ~$2.4–~$3.4 ; that spread sets a 15% margin before we rate Buy or Sell.

Produced by Fundamentalytics' automated valuation model on November 3, 2026, using delayed market prices. Rating meanings, methodology and conflicts: recommendations disclosure and research disclaimer. General research, not personal advice — it does not consider your circumstances. Prices can fall as well as rise.

Our value per share comes from a discounted-cash-flow model of Axil Brands, Inc.'s free cash flow after stock-based pay ( $568,836, FY2027 Q1 TTM, with after-tax interest added back): growth for five years as below (the first two years from forecasts, guidance and the company's record), fading to 2.5%, discounted at 8.5%, then cash added and debt and other claims subtracted. These are model values under stated assumptions, not price targets or recommendations.

Valuation models

We value Axil Brands, Inc. as an operating company, with every model that fits that kind of business. Cost of equity 8.6%: the 10-year Treasury yield (4.9%) plus a beta of 0.82 times a 4.5% equity risk premium.

Value per share by model
Model Value per share In the combined value?
Cash-flow model (DCF) Free cash flow to the firm (after stock pay, with after-tax interest added back), grown then faded to 2.5%, discounted at 8.5% as the firm rate, less debt and other claims. ~$2.9 ~$2.4–$3.4 Primary model, counts double
Price-to-earnings vs peers Earnings per share times peers' typical (harmonic-mean) price-to-earnings. ~$5.0 ~$3.6–$9.3 Included
Residual income Book value plus the present value of returns above the cost of equity, fading over ten years. ~$7.0 ~$4.8–$11 Included
Justified price-to-book Book value times (return on equity - growth) / (cost of equity - growth): steady-state returns. ~$5.6 ~$4.8–$6.8 Included
Combined value Weighted average of the models that apply: the primary model (cash-flow model (dcf)) counts double. Models more than 5x or less than 0.2x the share price, or more than 3x away from the other models' median, are left out. ~$4.7 ~$2.9–$7.0 4 models

Different models fail in different ways, so where several apply we average them rather than trust one. Peer-based models compare Axil Brands, Inc. with Personal Care Products in our coverage, using third-party market data. Model values are estimates under stated assumptions, updated as new filings arrive; not price targets or investment advice. How each model works.

What moves the value

  • Revenue growth 5 points lower ▼ −23%
  • Revenue growth 5 points higher ▲ +30%
  • Free-cash-flow margin 1 point lower ▼ −6%
  • Last year's free-cash-flow margin change, if it persists ▲ more than doubles
  • Discount rate 1 point higher ▼ −14%
Value per share under different assumptions
Discount rate ↓ / growth → −5% growth0% growth5% growth10% growth15% growth20% growth
7% $2$3$3$4$5$6
8.5% $2$2$3$3$4$5
10% $2$2$2$3$3$4

Valuation multiples over time Market data may be delayed

At fiscal year end 202420252026Now
Share price$8.68$6.15$6.71$5.95
Market value$70m$51m$55m$49m
+ Net debt (− = net cash)−$3m−$5m−$4m−$8m
Enterprise value$67m$46m$51m$41m
Multiples
Price / sales 2.6x1.9x1.8x1.6x
Price / earnings 35.0x59.1x20.5x17.6x
Price / free cash flow —29.5x—11.3x
EV / EBITDA 41.1x35.0x15.8x13.0x

Market value uses the period's diluted share count; figures for each fiscal year use that year's results and the price at year end. "Now" uses today's price and the last twelve months.

Moat

36 /100

Weak moat

How hard Axil Brands's competitive advantage looks for rivals to wear away, judged from 10 years of its own filings: returns on capital, pricing power, profit durability, cash conversion and discipline.

  • Returns on capital 0 / 20

    Net income has been a median 0.1% of total assets over 9 years.

  • Pricing power 12 / 20

    Gross margin has been a median 66.3%, moving by 13.1 percentage points (standard deviation) across 10 years.

  • Durability 10 / 20

    Operating margin has been a median -6.0%; its worst year was -104.5%.

  • Cash conversion 10 / 20

    Free cash flow was positive in 4 of 5 years, at a median 3.7% of revenue.

  • Discipline 9 / 20

    The diluted share count rose 301.7% over five years; stock-based pay has been a median 3.0% of revenue.

AI disruption exposure: Medium. In this industry, AI could change how the product is made or sold, without replacing the core asset. The score above includes a 5-point deduction for that exposure (41 before it).

A rules-based reading of reported figures, not a forecast and not investment advice. How the score is built: methodology.

Forecasts and guidance

Analysts' consensus

Fiscal yearEPSGrowthRevenueGrowth
Current $0.49 +49% $35m +12%
Next $0.75 +53% $42m +21%

How the EPS forecast has moved

The consensus EPS forecast for the current fiscal year is −44.3% on 90 days ago. In the last 30 days, 0 analysts raised Axil Brands, Inc.'s forecast and 1 cut it.

Consensus EPS forecast Axil Brands, Inc., last 90 days
$0.40 $0.60 $0.80 $1.00 90 days ago 60 days ago 30 days ago 7 days ago Now Current fiscal year, 90 days ago: $0.88 Current fiscal year, 60 days ago: $0.70 Current fiscal year, 30 days ago: $0.70 Current fiscal year, 7 days ago: $0.70 Current fiscal year, Now: $0.49 $0.49 Next fiscal year, 60 days ago: $0.93 Next fiscal year, 30 days ago: $0.93 Next fiscal year, 7 days ago: $0.93 Next fiscal year, Now: $0.75 $0.75

Average of analysts' published estimates (third-party data).

View chart data
Period Current fiscal yearNext fiscal year
90 days ago $0.88$0.93
60 days ago $0.70$0.93
30 days ago $0.70$0.93
7 days ago $0.70$0.75
Now $0.49$0.00

Earnings against estimates

Quarter toEstimateActualSurprise
Aug 2026 $0.13 $0.05 −61.5%
May 2026 $0.16 $0.18 +12.5%
Feb 2026 $0.15 $0.02 −86.7%

Adjusted EPS as companies report it, against the average analyst estimate.

Management guidance

Earnings release, October 6, 2026

No numeric guidance in Axil Brands, Inc.'s latest earnings release (filed October 6, 2026). Some companies give their outlook only on the earnings call.

How our valuation uses these forecasts

Our cash-flow model grows Axil Brands, Inc.'s revenue by +12.0% next year and +6.4% the year after, then fades back toward its own record by year five. Next year's rate weighs analysts' consensus (+21.4%, weight 45%) and the company's own record (+4.2%, weight 55%) . How the weights are set.

Positioning

Short interest
0.3%
of tradable shares
Days to cover
0.51
at average volume
Short interest, 1 month
+30%
to October 15, 2026
Held by institutions
15%
of shares
Held by insiders
40.3%
of shares
Employees
13
full time

Consensus figures average analysts' published estimates (third-party data); guidance is the company's own. Neither is our forecast. Short interest is reported twice a month and lags. Market data may be delayed.

This section is general information, not investment advice or a personal recommendation, and it does not take account of your objectives or circumstances. Forecasts and guidance are estimates, not promises: companies miss their own guidance and analysts' figures are often revised. Prices can fall as well as rise, and you can lose money. See our disclaimer.

Share-price performance

Market data may be delayed

What moved the share price

Last 12 months +6.4%

$5.59 on October 31, 2025 to $5.95

ThenNowEffect
Revenue (last 12 months) $27m $30m +10.3%
Net margin 4.8% 9.3% +94.3%
P/E multiple 37.6x 17.6x −53.1%
Share count 9m 8m +5.8%

Biggest factor: p/e multiple.

The effects multiply back to the price change exactly. Results are the last 12 months as known on each date (filings assumed public 45 days after quarter end).

Return and risk by year

Calendar year 20252026 to date
Return
AXIL+80%−14%
Industry peers (median)−34%+1%
S&P 500+18%+11%
Months that ended higher
AXIL50%27%
S&P 50075%46%
Largest fall from a high during the year
AXIL−55%−34%
S&P 500−19%−9%

Worst fall since February 14, 2024: 74% from February 23, 2024 to November 18, 2024. Getting back needed a 290% gain, and the shares have not yet recovered.

Price behaviour

52-week range
$4.75 – $8.69
From 52-week high
−31.5%
vs 50-day average
−0.9%
vs 200-day average
−6.8%
Volatility (1 year)
85%
Beta vs S&P 500
0.14

Volatility is the annualised standard deviation of daily returns. Beta 1.5 means the shares typically moved 1.5% for each 1% move in the S&P 500 over the past year. Prices to November 2, 2026.

Share price after results

Next day
5 up, 6 down
typical move ±5.3%
After a week
6 up, 5 down
typical move ±8.9%
After a month
6 up, 4 down
typical move ±17.6%
Results releasedNext dayS&P 500 next day5 days21 days
October 6, 2026 −1.8% +0.3% −4.6% —
August 18, 2026 −6.3% −0.5% −0.8% −3.2%
April 8, 2026 +2.1% +3.1% +1.4% +0.7%
January 8, 2026 +20.4% +0.7% +29.2% +8.1%
October 7, 2025 −2.7% +0.2% −1.8% −8.5%
August 21, 2025 −5.2% +1.1% −24.8% −7.8%
April 8, 2025 +7.3% +8.8% +10.3% +40.7%
January 8, 2025 +0.4% −1.4% +2.8% +69.3%
October 10, 2024 +2.5% +0.4% +6.2% +14.4%
August 15, 2024 −7.8% +1.9% −14.5% +9.6%
April 10, 2024 −1.6% −0.3% +1.5% −13.2%

From the close before the release date to the close 1, 5 and 21 trading days after it, so releases before the open and after the close are both captured. Past moves don't predict future ones.

Axil Brands, Inc. in five measures

Fundamentals grade B
Growth Profitability Cash Balance sheet Value

Growth, profitability, cash generation and balance sheet are percentiles against the companies we cover in the same industry, from SEC filings (100 = best). Value compares the share price with our modelled value range (50 = at our base value; higher = cheaper). A description of reported data and our model — not a quality score or advice.

Fundamentals

Revenue (TTM) Axil Brands, Inc.
$25M $30M $35M $40M FY24 Q2 FY25 Q1 FY25 Q4 FY27 Q1 Revenue (TTM), FY24 Q2: $37.6M Revenue (TTM), FY24 Q3: $38.4M Revenue (TTM), FY24 Q4: $27.5M Revenue (TTM), FY25 Q1: $27.2M Revenue (TTM), FY25 Q2: $26.6M Revenue (TTM), FY25 Q3: $27M Revenue (TTM), FY25 Q4: $26.3M Revenue (TTM), FY26 Q1: $27.3M Revenue (TTM), FY26 Q2: $27.7M Revenue (TTM), FY26 Q3: $28M Revenue (TTM), FY26 Q4: $30.8M Revenue (TTM), FY27 Q1: $30.1M $30.1M

Source: SEC EDGAR filings. Retrieved October 29, 2026.

View chart data
Period Revenue (TTM)
FY24 Q2 $37.6M
FY24 Q3 $38.4M
FY24 Q4 $27.5M
FY25 Q1 $27.2M
FY25 Q2 $26.6M
FY25 Q3 $27M
FY25 Q4 $26.3M
FY26 Q1 $27.3M
FY26 Q2 $27.7M
FY26 Q3 $28M
FY26 Q4 $30.8M
FY27 Q1 $30.1M
Revenue growth, TTM YoY Axil Brands, Inc.
-100% 0% 100% 200% 300% FY24 Q2 FY25 Q1 FY25 Q4 FY27 Q1 Revenue growth, TTM YoY, FY24 Q2: 214.0% Revenue growth, TTM YoY, FY24 Q3: 123.9% Revenue growth, TTM YoY, FY24 Q4: -19.2% Revenue growth, TTM YoY, FY25 Q1: -24.1% Revenue growth, TTM YoY, FY25 Q2: -29.4% Revenue growth, TTM YoY, FY25 Q3: -29.7% Revenue growth, TTM YoY, FY25 Q4: -4.5% Revenue growth, TTM YoY, FY26 Q1: 0.1% Revenue growth, TTM YoY, FY26 Q2: 4.2% Revenue growth, TTM YoY, FY26 Q3: 3.8% Revenue growth, TTM YoY, FY26 Q4: 17.5% Revenue growth, TTM YoY, FY27 Q1: 10.3% 10.3%

Source: SEC EDGAR filings. Retrieved October 29, 2026.

View chart data
Period Revenue growth, TTM YoY
FY24 Q2 214.0%
FY24 Q3 123.9%
FY24 Q4 -19.2%
FY25 Q1 -24.1%
FY25 Q2 -29.4%
FY25 Q3 -29.7%
FY25 Q4 -4.5%
FY26 Q1 0.1%
FY26 Q2 4.2%
FY26 Q3 3.8%
FY26 Q4 17.5%
FY27 Q1 10.3%
Operating margin (TTM) Axil Brands, Inc.
0% 5% 10% FY24 Q2 FY25 Q1 FY25 Q4 FY27 Q1 Operating margin (TTM), FY24 Q2: 6.0% Operating margin (TTM), FY24 Q3: 5.0% Operating margin (TTM), FY24 Q4: 5.5% Operating margin (TTM), FY25 Q1: 4.4% Operating margin (TTM), FY25 Q2: 2.3% Operating margin (TTM), FY25 Q3: 4.8% Operating margin (TTM), FY25 Q4: 4.4% Operating margin (TTM), FY26 Q1: 6.3% Operating margin (TTM), FY26 Q2: 7.0% Operating margin (TTM), FY26 Q3: 5.6% Operating margin (TTM), FY26 Q4: 9.7% Operating margin (TTM), FY27 Q1: 10.0% 10.0%

Source: SEC EDGAR filings. Retrieved October 29, 2026.

View chart data
Period Operating margin (TTM)
FY24 Q2 6.0%
FY24 Q3 5.0%
FY24 Q4 5.5%
FY25 Q1 4.4%
FY25 Q2 2.3%
FY25 Q3 4.8%
FY25 Q4 4.4%
FY26 Q1 6.3%
FY26 Q2 7.0%
FY26 Q3 5.6%
FY26 Q4 9.7%
FY27 Q1 10.0%
FCF margin (TTM) Axil Brands, Inc.
-5% 0% 5% 10% 15% FY21 Q3 FY24 Q1 FY24 Q4 FY27 Q1 FCF margin (TTM), FY21 Q3: 9.6% FCF margin (TTM), FY21 Q4: 2.0% FCF margin (TTM), FY23 Q4: 8.4% FCF margin (TTM), FY24 Q1: 6.7% FCF margin (TTM), FY24 Q2: 5.0% FCF margin (TTM), FY24 Q3: 2.2% FCF margin (TTM), FY24 Q4: -0.5% FCF margin (TTM), FY26 Q1: 0.0% FCF margin (TTM), FY26 Q2: -0.1% FCF margin (TTM), FY26 Q3: 3.0% FCF margin (TTM), FY26 Q4: -0.3% FCF margin (TTM), FY27 Q1: 14.5% 14.5%

Source: SEC EDGAR filings. Retrieved October 29, 2026.

View chart data
Period FCF margin (TTM)
FY21 Q3 9.6%
FY21 Q4 2.0%
FY23 Q4 8.4%
FY24 Q1 6.7%
FY24 Q2 5.0%
FY24 Q3 2.2%
FY24 Q4 -0.5%
FY26 Q1 0.0%
FY26 Q2 -0.1%
FY26 Q3 3.0%
FY26 Q4 -0.3%
FY27 Q1 14.5%

Data: SEC EDGAR XBRL company facts (as filed in 10-K/10-Q); forms 10-K, 10-K/A, 10-Q. Generated November 3, 2026. Definitions in our methodology.

Where the money goes

FY2026, from the 10-K

Each dollar Axil Brands took in during FY2026, followed through to profit: what it cost to make, what went on running the business, and what was left after tax.

  1. Revenue $30.8M
  2. Other income $162,616 · 0.5%
  3. Cost of revenue $9.4M · 30.5%
  4. Gross profit $21.4M · 69.3%
  5. Selling, general and admin $16.3M · 52.8%
  6. Other operating costs $2.1M · 6.9%
  7. Operating income $3M · 9.7%
  8. Income tax $440,310 · 1.4%
  9. Net income $2.7M · 8.8%

Shares of revenue. Source: Axil Brands's 10-K for FY2026, as filed with the SEC. "Other" lines are what the reported lines leave unexplained. Other income is income outside operations, such as investment gains.

Financial statements

US$ millions unless shown otherwise. Fiscal years, plus the last twelve months (LTM) when newer.

Fiscal year 2017 May 2017 2018 May 2018 2019 May 2019 2020 May 2020 2021 May 2021 2022 May 2022 2023 May 2023 2024 May 2024 2025 May 2025 2026 May 2026 LTM Aug 2026
Income
Revenue 1 1 1 1 2 2 24 27 26 31 30
Gross profit 0 0 0 1 1 2 18 20 19 21 22
EBITDA −1 −0 −0 −0 −0 −0 2 2 1 3 3
Operating income −1 −0 −0 −0 −0 −0 2 2 1 3 3
Net income −1 −0 −0 −0 −0 −0 2 2 1 3 3
Diluted EPS −$0.40 −$0.40 $0.00 $0.00 −$0.40 $0.00 $0.20 $0.42 $0.10 $0.33 $0.34
Growth (year on year)
Revenue — +60.3% +6.4% +2.0% +61.3% +43.0% +906.8% +16.9% −4.5% +17.5% +10.3%
EBITDA — — — — — — — −21.4% −19.8% +146.1% +66.6%
Operating income — — — — — — — −24.2% −22.7% +156.3% +75.2%
Net income — — — — — — — +9.8% −57.3% +215.7% +114.4%
Diluted EPS — — — — — — — +110.0% −76.2% +230.0% +126.8%
Margins
Gross margin 51.6% 38.3% 44.3% 52.5% 63.3% 64.5% 75.3% 73.4% 71.0% 69.3% 72.4%
EBITDA margin −92.2% −36.0% −14.5% −15.9% −19.0% −8.7% 8.8% 5.9% 5.0% 10.5% 10.6%
Operating margin −92.5% −36.3% −15.1% −16.9% −19.7% −9.0% 8.4% 5.5% 4.4% 9.7% 10.0%
Net margin −92.6% −36.7% −15.1% −17.1% −18.2% −7.8% 7.8% 7.3% 3.3% 8.8% 9.3%
Free-cash-flow margin −64.5% −50.6% −19.0% −9.8% 2.0% — 12.1% −0.5% 6.5% −0.3% 14.5%
Cash flow
Cash from operations −0 −0 −0 −0 0 −0 3 0 2 −0 4
Capital spending 0 0 0 0 0 — 0 0 0 0 0
Free cash flow −0 −0 −0 −0 0 — 3 −0 2 −0 4
Stock-based pay 0 0 0 0 0 0 0 0 1 1 1
Free cash flow after stock pay −1 −1 −0 −0 −0 — 3 −0 1 −1 3
Balance sheet
Cash 0 0 0 0 0 0 5 3 5 4 8
Total debt 0 0 0 0 0 0 0 0 0 0 0
Net debt (negative = net cash) −0 −0 −0 −0 −0 −0 −4 −3 −5 −4 −8
Diluted shares — 1m 1m 1m 1m 1m 9m 8m 8m 8m 8m
Returned to shareholders
Buybacks — — — — — — — 1 — — —
Total returned — — — — — — — 1 — — —

Source: SEC EDGAR XBRL company facts (US and foreign periodic filings); column headings link to the filing. EBITDA is operating income plus depreciation and amortisation. Free cash flow is cash from operations minus capital spending. Growth is left blank when last year's figure was a loss or under 2% of revenue. Share counts and EPS are restated for stock splits. A dash means the company didn't report the figure.

Financial health

3 of 3 checks passed · August 31, 2026
What it owns · $19m
Short-term assets $15mLonger-term assets $4m
What it owes, and who funded it · $18m
Short-term liabilities $4mLonger-term liabilities $0mShareholders' equity $14m
  • Short-term assets cover short-term liabilities $15m of assets due within a year against $4m of liabilities due within a year.
  • Short-term assets cover long-term liabilities $15m short-term assets against $242,256 of longer-dated liabilities.
  • More cash than debt Cash or debt not separately reported. Not assessable.
  • Debt below 40% of shareholders' equity Equity or debt not reported. Not assessable.
  • Debt burden no higher than five years ago Five-year comparison not available. Not assessable.
  • A year's operating cash flow covers at least 20% of debt Cash flow or debt not reported. Not assessable.
  • Operating profit covers interest at least five times over Operating income of $3m against $2,587 of interest.

From Axil Brands, Inc.'s latest balance sheet as filed. Checks are fixed, documented rules (methodology), counted only where the company reports the figures — a dot means the filing doesn't break the item out. Descriptions of reported data, not advice.

Dividends, buybacks and capital spending

Diluted share count
−5.5%
year over year

Competitors: side by side with peers

Closest by revenue in personal care products
Last 12 months unless stated AXIL NHTC FTLF YCBD UG MTEX Median
Revenue, last 12 months $30m $34m $36m $21m $11m $107m $913m
Revenue growth, last 12 months 10.3% −16.5% −43.3% 10.0% 3.2% −5.0% 3.5%
Revenue growth, 3-year average −5.7% −9.1% −3.0% −7.3% 2.5% −7.7% −0.1%
Revenue growth, latest quarter −11.2% −20.2% 64.6% 20.6% 9.5% 3.8% 2.7%
Gross margin 72.4% 74.3% 34.8% 57.7% 46.9% 76.1% 69.2%
Operating margin 10.0% −5.9% 10.9% −13.9% 20.8% 2.5% 6.7%
Operating margin, 3-year average 6.9% −4.1% 16.0% −37.2% 25.5% 0.4% 5.5%
Net margin 9.3% −4.2% 5.4% −13.8% 22.0% −6.9% 3.4%
Cash from operations / revenue 14.9% −12.3% 28.1% −10.6% 30.9% 2.3% 9.9%
Free-cash-flow margin 14.5% −13.7% 28.0% −11.5% 30.3% 1.5% 9.6%
Free-cash-flow margin, 3-year average 7.1% −11.4% 17.7% −7.8% 26.4% −1.0% 6.0%
Stock pay / revenue 4.3% 0.1% 0.1% 4.2% — 0.4% 1.0%
Change in share count −5.5% −15.7% 0.5% — 0.0% 1.2% −0.0%

Median of all 21 companies we cover in personal care products. Shaded: best of the six on that line (lowest for stock pay and share-count growth). 3-year figures average the last three 12-month periods; 3-year growth is compound annual. Source: SEC filings.

Peer comparison

21 personal care products companies
Measure Company Peer median Rank
Revenue growth Growth 10.3% 3.5% 4 of 21
Change in growth rate Growth -7.1pp +0.7pp 20 of 21
Gross margin Profitability 72.4% 69.2% 10 of 21
Operating margin Profitability 10.0% 6.7% 8 of 21
Net margin Profitability 9.3% 3.4% 6 of 21
Free-cash-flow margin Cash generation 14.5% 9.6% 8 of 21
Stock pay as % of revenue Cash generation 4.3% 1.0% 17 of 18
Long-term debt as % of assets Balance sheet 0.9% 29.7% 1 of 13
Change in share count Balance sheet -5.5% -0.0% 3 of 19

Rank 1 = best in the group (for spending, debt and dilution, lower ranks first).

Where the revenue comes from

Fiscal year to May 31, 2026
Segments
Line of business Revenue Share YoY
Hearing Enhancement and Protection $29.6M 95.8% ▲ 19.5%
Hair and Skin Care $1.2M 3.9% ▼ 21.9%
Marketing Services $100,000 0.3% —
Products and services
Line of business Revenue Share YoY
Direct To Consumer $19.9M 64.8% ▼ 4.5%
Retail and Wholesale $10.8M 35.2% ▲ 100.7%

From Axil Brands, Inc.'s 10-K filed August 18, 2026, as tagged in the filing. View filing. Indented rows are part of the line above; their share is of that line. In the bars, the faint bar behind is the year before.

Who owns it

Funds buying and selling
Reported value
$6.9M
Institutions reporting
14
Shares held vs prior quarter
▲ 13.6%
Positions opened / closed
3 / 3

Top buyers and sellers, Q2 2026: 7 institutions bought and 5 sold ; the biggest buyer was Diversify Advisory Services, LLC (+164K shares) and the biggest seller Fny Investment Advisers, LLC (−40K). See which funds bought and sold →

Largest reported holders, June 30, 2026
Manager Value Shares Share of 13F value Shares QoQ
Private Advisory Group LLC $2.2M 335K 32.5% 0.0%
Soltis Investment Advisors LLC $1.2M 180K 17.5% 0.0%
Diversify Advisory Services, LLC $985,986 164K 14.3% New
Diversify Wealth Management, LLC $985,986 164K 14.3% ▼ 11.9%
Vanguard Capital Management LLC $471,539 70K 6.8% ▲ 17.9%
Wells Fargo & Company $265,910 40K 3.9% 0.0%
Geode Capital Management, LLC $256,341 38K 3.7% 0.0%
Vanguard Fiduciary Trust Co $132,533 20K 1.9% ▲ 0.7%
Blackrock, Inc. $91,154 14K 1.3% ▲ 34.4%
Citadel Advisors LLC $87,361 13K 1.3% New
State Street Corp $84,916 13K 1.2% 0.0%
Cetera Investment Advisers $73,700 11K 1.1% ▼ 15.4%

From Form 13F filings with the SEC ( quarterly data sets), as reported by each manager for June 30, 2026 and filed up to 45 days later. 13F reports cover long US-listed positions of managers above $100M only, so this is not Axil Brands, Inc.'s complete shareholder register. Values are as reported by the filers .

Insider trading activity

Full insider history and chart
Insider purchases History → $0 0 trades by 0 insiders, last 12 months Insider sales History → $0 0 trades by 0 insiders
Net ▲ $0 net buying

No open-market insider trades reported in the last 12 months.

From insiders' Form 4 filings with the SEC. Excludes awards, option exercises and shares withheld for tax. "Pre-set plan" means the filing marks the trade as made under a Rule 10b5-1 plan. See every insider trade since five years ago, on a price chart.

Earnings dates and SEC filings

Results announcements

Next expected around January 7, 2027 estimated from the company's past filing pattern, not announced

  • October 6, 2026
  • August 18, 2026
  • April 8, 2026
  • January 8, 2026
  • October 7, 2025
  • August 21, 2025

Recent SEC filings

Data status

When each part of this page on Axil Brands, Inc. was last updated.

DataLast updatedSource
Share priceExchange closing prices
Financial statementsSEC 10-K and 10-Q filings
News and updatesCompany releases and SEC 8-K filings
Analyst estimatesAggregated analyst estimates
Valuation and scoresOur models, from the filed figures

How we build and check these figures: methodology and data sources.

Axil Brands, Inc. in brief

What does Axil Brands, Inc. do?
Axil Brands, Inc. is a US-listed company in the personal care products industry. Its financial year ends in May.
What is Axil Brands, Inc.'s stock ticker?
Axil Brands, Inc. trades under the ticker AXIL on NYSE. This page brings together its financial statements, valuation models, ownership and recent company updates.
What is Axil Brands, Inc.'s revenue, and how fast is it growing?
Over its most recent trailing twelve months, Axil Brands, Inc. reported revenue of $30.1M, 10.3% higher than a year earlier, according to its SEC filings.
What is Axil Brands, Inc.'s free cash flow?
Axil Brands, Inc.'s free-cash-flow margin is 14.5% of revenue over the trailing twelve months, ranking 8 of the 21 personal care products companies we cover.
What is Axil Brands, Inc.'s fair value (intrinsic value) per share?
Our discounted-cash-flow model of Axil Brands, Inc.'s free cash flow after stock-based pay gives ~$2.9 per share in the base case, and ~$2.4–$3.4 across growth scenarios. These are model values under stated assumptions — not a price target or a recommendation.
Who are Axil Brands, Inc.'s largest institutional shareholders?
By value reported in 13F filings for June 30, 2026, the largest reported holders are Private Advisory Group LLC, Soltis Investment Advisors LLC and Diversify Advisory Services, LLC. 13F reports cover long US-listed positions of managers above $100M, filed up to 45 days after quarter end.
What is Axil Brands, Inc.'s market cap?
On November 2, 2026, Axil Brands, Inc.'s market capitalisation was about $49.1M, with a price-to-earnings ratio of 17.6 and net debt of -$7.8M. Market figures come from third-party market data and may be delayed.
Who are Axil Brands, Inc.'s competitors?
In our Personal Care Products peer group, the companies closest to Axil Brands, Inc. are Natural Health Trends Corp, Fitlife Brands, Inc., Cbdmd, Inc., United Guardian Inc and Mannatech Inc. The side-by-side comparison below sets their revenue, margins and growth against Axil Brands, Inc.'s.
When is Axil Brands, Inc.'s next earnings date?
Around January 7, 2027, estimated from the spacing of its past results announcements (8-K filings). That is an estimate, not a confirmed date — Axil Brands, Inc. announces its own schedule.